The links between obesity, inflammation and insulin resistance, which are all key characteristics of type 2 diabetes mellitus, are yet to be delineated in the brain. One of the key neuroinflammatory proteins detected in the hypothalamus with over-nutrition is tumour necrosis factor (TNF)α. Using immortalised embryonic rat and mouse hypotha- IκBα, Tnfrsf1a and IL6 at 4 and 24 hours, activating a pro-inflammatory state. An inhibitor study using an inhibitor of nuclear factor kappa B kinase subunit β (IKK-β) inhibitor, PS1145, demonstrated that TNFα-induced neuroinflammatory marker expression occurs through the IKK-β/nuclear factor-kappa B pathway, whereas oleate, a monounsaturated fatty acid, had no effect on inflammatory markers. To test the efficacy of anti-inflammatory treatment to reverse insulin resistance, neurones were treated with TNFα and PS1145, which did not significantly restore the TNFα-induced changes in cellular insulin sensitivity, indicating that an alternative pathway may be involved. In conclusion, exposure to the inflammatory cytokine TNFα causes cellular insulin resistance and inflammation marker expression in the rHypoE-7 and mHypoE-46 neurones, consistent with effects seen with TNFα in peripheral tissues. It also mimics insulin-and palmitate-induced insulin resistance in hypothalamic neurones. The present study provides further evidence that altered central energy metabolism may be caused by obesity-induced cytokine expression.
| INTRODUC TI ON
Obesity is approaching epidemic levels and is associated with an increased risk of metabolic disorders. 1 One of the main characteristics of obesity is the development of insulin resistance, leading to other comorbidities, such as type 2 diabetes mellitus (T2DM) and cardiovascular disease. Obesity has also been correlated with an increase in low-grade inflammation, which is linked to an increase of tumour necrosis factor (TNF)α and other circulating cytokines. 2 Some studies have shown that TNFα is associated with an increased risk in developing T2DM, acting through an intersection of the TNFα and insulin signalling pathways to induce insulin resistance, a key characteristic in T2DM. 3 Insulin resistance is also induced in peripheral tissues, such as the liver, muscle and adipocytes, by the pro-inflammatory cytokine TNFα. Although a wealth of literature has focused on the link between inflammation and insulin resistance in peripheral metabolic tissues, further investigations are required regarding neuroinflammation as a central regulator of energy homeostasis in the hypothalamus.
The hypothalamus is the main brain region responsible for central energy regulation, housing distinct populations of neurones that influence food intake and energy expenditure. The hypothalamic arcuate nucleus houses neuropeptide Y (NPY), agouti-related peptide (AgRP) and pro-opiomelanocortin (POMC) neurones, which produce neuropeptides to regulate feeding behaviour. [4] [5] [6] [7] When activated, NPY/AgRP-expressing neurones act to increase feeding and decrease bodily energy expenditure, whereas activation of POMCexpressing neurones has the opposite effect. Importantly, these neurones are sensitive to peripheral signals, including leptin, ghrelin and insulin, which modulate the activity of these neurones.
Arcuate nucleus cell populations express the insulin receptor (IR);
consequently, NPY/AgRP neurones are inhibited by insulin to promote an anabolic state. 8 Insulin resistance, which is of particular interest to the present study, can potentially dysregulate physiological energy homeostasis. Previous in vitro studies have demonstrated the induction of hypothalamic insulin resistance with long-term insulin exposure, 9 as well as after treatment with palmitate, a saturated fatty acid and an abundant component of a high-fat diet. 10 Palmitate is also known to induce hypothalamic inflammatory marker gene expression, including TNFα, both in vivo and in vitro. [11] [12] [13] Additionally, high levels of chronic palmitate treatment resulted in cellular insulin resistance. Thus, we considered whether TNFα, as induced by palmitate exposure, had similar effects. Independent of palmitate signalling, circulating TNFα itself may potentially affect the physiological hormone sensitivity of arcuate neurones. Accordingly, the main focus of the present study was to investigate the response of NPY/AgRPexpressing neurones to TNFα exposure, particularly the modulation of cellular insulin sensitivity and neuroinflammatory activation.
As a result of the vast heterogeneity of the hypothalamus, immortalised cell lines provide a useful model for studying factors that regulate individual hypothalamic neuronal populations. In the present study, we employed immortalised neurones to investigate cellular insulin sensitivity and neuroinflammation. Specifically, the embryonic rat rHypoE-7 and mouse mHypoE-46 cell lines were chosen as appropriate in vitro models because of their characterised expression of NPY and AgRP, inflammatory signalling, and sensitivity to several hormones, including insulin. 9, [14] [15] [16] It was demonstrated previously that the mHypoE-46 cell line exhibits an increase in neuroinflammatory markers with TNFα and palmitate exposure.
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Whether this induction of neuroinflammatory markers is linked to reduced insulin sensitivity was explored in the present study.
To test the overall hypothesis that TNFα increases the expression of pro-inflammatory gene markers and induces insulin resistance in immortalised hypothalamic neurones, cells were treated with TNFα in vitro. Measurement of insulin sensitivity and the induction of inflammatory markers demonstrated that TNFα causes insulin resistance and induces cellular neuroinflammation in hypothalamic neurones. Inhibitor studies demonstrated that TNFα-mediated inflammatory activation occurs in an inhibitor of nuclear factor kappa B kinase subunit β (IKK-β)/nuclear factor kappa B (NF-κB)-dependent manner; however, the induction of insulin resistance appears to be independent of the IKK-β/NF-κB pathway.
| MATERIAL S AND ME THODS

| Cell culture and reagents
Embryonic rat and mouse hypothalamic neurones were immortalised by retroviral transfer of SV-40 T-antigen in primary hypothalamic cultures, as described previously. 
| Quantitative real-time RT-PCR (qRT-PCR)
Neurones were grown to 70%-80% confluency on 60-mm plates in DMEM (supplemented with 5% FBS and 1% P/S) prior to treatment. rHypoE-7 and mHypoE-46 neurones were treated with with gene-specific primers. Primer sequences are listed in Table 1 .
Samples were run in triplicate on the Prism 7000 sequence Detection System (Applied Biosystems). qRT-PCR data analysis was performed using standard curve method and normalised to the reference gene encoding histone 3A.
| qPCR inflammatory array
rHypoE-7 neurones were grown to 70-80% confluency on 60-mm plates in DMEM (supplemented with 2% FBS and 1% P/S) prior to treatment. Cells were treated for 4 hours with TNFα (100 ng mL -1 ) prior to RNA isolation (n = 3 independent experiments). RNA was isolated using PureLink RNA Kit with on-column PureLink DNase (Ambion). cDNA was then synthesised using the high capacity cDNA reverse transcription kit (Applied Biosystems 
| Statistical analysis
Data were analysed using prism, version 6.0 (GraphPad Software Inc., La Jolla, CA, USA) and are shown as the mean ± SEM. The n-value for each experiment refers to the number of biological replicates performed. Statistical significance was determined by one-or twoway ANOVA, as indicated, followed by Bonferroni's post-hoc test.
P < 0.05 was considered statistically significant.
| RE SULTS
| TNFα exposure attenuates insulin signalling in rHypoE-7 neurones
Neurones of the hypothalamic arcuate nucleus are functionally responsive to peripheral hormones, which, in turn, are capable of al- 
| TNFα alters IR and IRS-1 mRNA expression but not IR protein levels
There is evidence that alterations to IR and related signalling proteins can lead to attenuated insulin signalling. 
| Short-term TNFα exposure decreases AgRP but not NPY expression in mHypoE-46 neurones
Given previous evidence suggesting cytokine exposure can alter feeding-related neuropeptides in NPY/AgRP-expressing neurones, 
| TNFα induces pro-inflammatory gene expression in rHypoE-7 neurones
Hypothalamic insulin signalling is attenuated by exposure to palmitate, 10 a saturated fatty acid that leads to the induction of several inflammatory markers, including TNFα. 
| PS1145 pre-treatment does not alleviate
TNFα-induced insulin resistance
Inhibition of the IKK-β/NFκB signalling pathway has previously been shown to prevent cellular insulin resistance caused by TNFα and fatty acids. 25, 26 As such, we inhibited IKK-β using the inhibitor 
| D ISCUSS I ON
Chronic low-grade inflammation has been implicated in the pathogenesis of obesity and T2DM and has been shown to occur with high-fat consumption. 11, 27, 28 A ubiquitous component of a high-fat diet is the saturated fatty acid palmitate. Some palmitate-activated signalling pathways in hypothalamic cells and tissue have been characterised, which includes the induction of pro-inflammatory cytokine expression. 11, 13, 24 Inflammation-induced alterations to hypothalamic neurones expressing feeding-related peptides have the potential to induce feeding dysregulation and exacerbate obesity.
As a result of the increase in TNFα mRNA expression by palmitate shown previously in our laboratory, 13 we were interested in investigating the effects of TNFα-induced inflammation in the context of insulin resistance in the hypothalamic arcuate nucleus. We also aimed to specifically determine whether TNFα itself induces hypothalamic neuroinflammation and insulin resistance, as well as the mechanisms by which these occur. We investigated this issue using immortalised clonal hypothalamic cell models, the rat-derived rHy- TNFα attenuates insulin signalling in the rHypoE-7 neuronal line, implicating the role of cellular neuroinflammation in hypothalamic insulin sensitivity. Neurones of the hypothalamic arcuate nucleus are sensitive to insulin, which is known to decrease the physiological feeding drive by attenuating NPY and AgRP expression. 14 Palmitate, in addition to the induction of hypothalamic neuroinflammation, has also been reported to cause cellular insulin resistance in hypothalamic neurones. 10 Central hypothalamic insulin signalling is significant because it is involved in regulating hepatic glucose production;
indeed, central insulin resistance is shown to occur prior to similar changes in peripheral tissues. Furthermore, it should be considered that functional alterations to the IR itself have been reported in insulin resistance models, including phosphorylation of tyrosine residues 37 or lysosomal degradation.
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In the periphery, TNFα is known to impair insulin sensitivity by the activation of signalling serine kinases, such as IKK and c-Jun N-terminal kinase (JNK), [38] [39] [40] which are involved in inflammatory signalling cascades. These kinases have been shown to phosphorylate components of the insulin signalling pathway, including the IR and IR substrate proteins, altering their function. 40 Because it is unclear whether TNFα reduces insulin sensitivity in this manner, further identification of the modifications of IR and IRS-1 will be optimal to further clarify this mechanism.
Furthermore, our results demonstrate that components of the IKK-β/NF-κB signalling pathway are activated upon exposure to neurones. 15 Oleate, an unsaturated fatty acid abundant in olive oil, 46 has been demonstrated to be protective against palmitate-induced inflammation 24 and insulin resistance 23 in neuronal cell models.
Furthermore, oleate co-treatment completely blocks the induction of IL-6 mRNA expression by palmitate in hypothalamic neuronal models. 24 As such, we tested the ability of oleate to block neuroinflammation caused by TNFα exposure in the mHypoE-46 and rHypoE-7
neurones. Oleate co-treatment did not alleviate TNFα-induced IκBα expression as expected, suggesting a separate mechanism of action compared to palmitate-induced cellular neuroinflammation.
Salicylate and metformin are anti-inflammatory molecules that have been proven effective in blocking inflammatory marker expression in response to TNFα and palmitate. 13 Salicylate is implicated as an IKK-β inhibitor, 26, 47 and both salicylate and metformin activate the energy sensor AMPK. 48, 49 The protective effects of metformin and salicylate appear to be synergistic, with combination treatment resulting in higher activation of AMPK 49, 50 and reducing inflammatory marker mRNA expression. 13 Indeed, pre-and co-treatment with a metformin/ salicylate combination in mHypoE-46 neurones blocked the induction of IL-6 mRNA by palmitate but not by TNFα, 13 which is similar to the results seen with the PS1145-mediated IKK-β inhibition in the present study. However, it is not known whether the ability of metformin and salicylate to block IL-6 induction could lead to a reversal of cytokineor fatty acid-mediated insulin resistance in hypothalamic neurones. A mechanistic study employing the use of these drugs may reveal the potential to reverse hypothalamic insulin resistance.
TNF-R1 (p55), one of two major TNFα receptors, is expressed in the arcuate nucleus of the rat brain. 51 Characterisation of the se- 
ACK N OWLED G EM ENTS
We acknowledge funding received from the Canadian Institutes 
CO N FLI C T O F I NTE R E S T S
The authors declare that they have no conflicts of interest.
O RCI D
Denise D. Belsham https://orcid.org/0000-0002-7065-8591
